Role of mitochondrial permeability transition in taurine deficiency-induced apoptosis

Experimental and Clinical Cardiology

Volumn 16, Issue 4, 2011, Pages 125-128

  Jong, Chian Ju ^a   Azuma, Junichi ^b   Schaffer, Stephen W ^a  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Apoptosis; Mitochondrial permeability transition; Oxidative stress; Taurine deficiency

Indexed keywords

BETA ALANINE; CALCIUM; CYCLOSPORIN A; GLUTATHIONE; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; REACTIVE OXYGEN METABOLITE; TAURINE;

AMINO ACID DEFICIENCY; ANIMAL CELL; APOPTOSIS; ARTICLE; CYTOSOL; HEART MUSCLE CELL; MITOCHONDRIAL PERMEABILITY; NONHUMAN; OXIDATIVE STRESS; RAT;

EID: 80055115774     PISSN: 12056626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Huxtable RJ. Physiological actions of taurine. Physiol Rev 1992;72:101-63.
2. Yokogoshi H, Mochizuki H, Nanami K, Hida Y, Miyachi F, Oda H. Dietary taurine enhances cholesterol degradation and reduces serum and liver cholesterol concentrations in rats fed a high-cholesterol diet. J Nutr 1999;129:1705-12. (Pubitemid 29406625)
3. Schuller-Levis GB, Park E. Taurine: New implications for an old amino acid. FEMS Microbiol Lett 2003;226:195-202. (Pubitemid 38444940)
4. Jong CJ, Azuma J, Schaffer S. Mechanism underlying the antioxidant activity of taurine: Prevention of mitochondrial oxidant production. Amino Acids 2011. (In press)
5. Suzuki T, Suzuki T, Wada T, Saigo K, Watanabe K. Taurine as a constituent of mitochondrial tRNAs: New insights into the functions of taurine and human mitochondrial diseases. Embo J 2002;21:6581-9. (Pubitemid 35448435)
6. Kurata S, Weixlbaumer A, Ohtsuki T, et al. Modified uridines with C5-methylene substituents at the first position of the tRNA anticodon stabilize U-G wobble pairing during decoding. J Biol Chem 2008;283:18801-11.
7. Schaffer SW, Azuma J, Mozaffari M. Role of antioxidant activity of taurine in diabetes. Can J Physiol Pharmacol 2009;87:91-9.
8. Schaffer S, Azuma J, Takahashi K, Mozaffari M. Why is taurine cytoprotective? Adv Exp Med Biol 2003;526:307-21.
9. Lang F, Madlung J, Siemen D, Ellory C, Lepple-Wienhues A, Gulbins E. The involvement of caspases in the CD95 (Fas/Apo-1)- but not swelling-induced cellular taurine release from Jurkat T-lymphocytes. Pflugers Arch 2000;440:93-9. (Pubitemid 30265915)
10. Lang F, Busch GL, Ritter M, et al. Functional significance of cell volume regulatory mechanisms. Physiol Rev 1998;78:247-306. (Pubitemid 28070981)
11. Kramer JH, Chovan JP, Schaffer SW. Effect of taurine on calcium paradox and ischemia heart failure. Am J Physiol 1981;240:H238-H246. (Pubitemid 11155920)
12. Nahashima T, Seto Y, Nakajima T, et al. Calcium-associated cytoprotective effect of taurine on the calcium and oxygen paradoxes in isolated hepatocytes. Liver 1990;10:167-72. (Pubitemid 20376294)
13. Grishko V, Pastukh V, Solodushko V, Gillespie M, Azuma J, Schaffer SW. Apoptotic cascade initiated by angiotensin II in neonatal cardiomyocytes: Role of DNA damage. Am J Physiol 2003;285:H2364-H2372. (Pubitemid 37443052)
14. Schaffer SW, Solodushko V, Kakhniashvili D. Beneficial effect of taurine depletion on osmotic sodium and calcium loading during chemical hypoxia. Am J Physiol 2002;282:C1113-C1120. (Pubitemid 34663120)
15. Shaffer JE, Kocsis JJ. Methods of reducing tissue taurine levels. In: SW Schaffer, SI Baskin, Kocsis JJ, eds. The effects of taurine on excitable tissues. New York: Spectrum, 1981:219-29.
16. Ricci C, Pastukh V, Schaffer SW. Involvement of the mitochondrial permeability transition pore in angiotensin II-mediated apoptosis. Exp Clin Cardiol 2005;10:160-4. (Pubitemid 41227225)
17. Ashkenazi A, Dixit VM. Death receptors: Signaling and modulation. Science 1998;281:1305-8. (Pubitemid 28406815)
18. Nakagawa T, Zhu H, Horishima N, et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 2000;403:98-103. (Pubitemid 30038529)
19. Hacker G, Weber A. BH3-only proteins trigger cytochrome c release, but how? Arch Biochem Biophys 2007;462:150-5. (Pubitemid 46856314)
20. 2+-independent mechanisms that are regulated by Bax. J Biol Chem 2001;276:19066-71.
21. Schaffer S, Solodushko V, Pastukh V, Ricci C, Azuma J. Possible cause of taurine deficient cardiomyopathy: Potentiation of angiotensin II action. J Cardiovasc Pharmacol 2003;41:751-9. (Pubitemid 36523178)
22. Halestrap AP. What is the mitochondrial permeability transition pore? J Mol Cell Cardiol 2009;46:821-31.
23. Halestrap AP, Woodfield KY, Connern CP. Oxidative stress, thiol reagents and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocase. J Biol Chem 1997;272:3346-54.
24. Griffiths EJ, Bell CJ, Balaska D, Rutter GA. Mitochondrial calcium: Role in the normal and ischaemic/reperfused myocardium. In: SW Schaffer, Suleiman MS, eds. Mitochondria: The dynamic organelle. New York: Springer Science and Business Media, LLC, 2007:197-220.
25. Aon MA, Cortassa S, Maack C, O'Rouke B. Sequential opening of mitochondrial ion channels as a function of glutathione redox thiol status. J Biol Chem 2007;282:21889-900. (Pubitemid 47195754)
26. Novotny MJ, Hogan PM, Flannigan G. Echocardiographic evidence for myocardial failure induced by taurine deficiency in domestic cats. Can J Vet Res 1994;58:6-12.
27. Pion PD, Kittleson MD, Rogers QR, Morris JG. Myocardial failure in cats associated with low plasma taurine: A reversible cardiomyopathy. Science 1987;237:764-8. (Pubitemid 17128269)
28. Ito T, Kimura Y, Uozumi Y, et al. Taurine deletion caused by knocking out the taurine transporter gene leads to a cardiomyopathy with cardiac atrophy. J Mol Cell Cardiol 2008;44:927-37.
29. Kang PM, Izumo S. Apoptosis and heart failure. Circ Res 2000;86:1107-13.
30. van Eijsden RGE, Eijssen LMT, Lindsey PJ, et al. Termination of damaged protein repair defines the occurrence of symptoms in carriers of the m.3243A>G tRNALeu mutation. J Med Genet 2008;45:525-34.
31. Yasukawa T, Suzuki T, Suzuki T, Ueda T, Ohta S, Watanabe K. Modification defect at anticodon wobble nucleotide of mitochondrial tRNAsLeu(UUR) with pathogenic mutations of mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes. J Biol Chem 2000;275:4251-7. (Pubitemid 30094664)
32. Halestrap AP, Brenner C. The adenine nucleotide translocase: A central component of the mitochondrial permeability transition pore and key player in cell death. Curr Med Chem 2003;10:1507-25. (Pubitemid 36896553)
33. Ide T, Tsutsui H, Kinugawa S, et al. Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing heart. Circ Res 1999;85:357-63. (Pubitemid 29398868)
34. Chen Q, Vazquez EJ, Moghaddas S, Hoppel CL, Lesnefsky EJ. Production of reactive oxygen species by mitochondria: Central role of complex III. J Biol Chem 2003;278:36027-31. (Pubitemid 37139922)
35. Thu VT, Kim HK, Ha SH, et al. Glutathione peroxidase I protects mitochondria against hypoxia/reoxygenation damage in mouse hearts. Pflugers Arch 2010;460:55-68.